GWM
KRYS icon

GK Wealth Management’s Krystal Biotech KRYS Stock Holding History

GK Wealth Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$58.9K Buy
+177
New +$61.3K 0.03% 420

Other funds holding KRYS

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
NWMP
Noble Wealth Management PBC Greenwood Village, Colorado $223M AUM 7.64% 1-Year Est. Return

GK Wealth Management's KRYS Position: Q3 2026 in Review

GK Wealth Management opened a new position in Krystal Biotech (KRYS) in Q3 2026: 177 shares worth $58.9K. The stake represents 0.03% of the portfolio and ranks #420 among its holdings.

11 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • GK Wealth Management held 177 shares of Krystal Biotech worth $58.9K as of Q3 2026.
  • Krystal Biotech was a new GK Wealth Management position in Q3 2026.
  • Krystal Biotech made up 0.03% of GK Wealth Management's portfolio in Q3 2026, its #420 holding.
  • 11 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.